{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:42:21Z","timestamp":1791430941979,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008538","name":"UCL Faculty of Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/H046410\/1"],"award-info":[{"award-number":["EP\/H046410\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/H046410\/1"],"award-info":[{"award-number":["EP\/H046410\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/J020990\/1"],"award-info":[{"award-number":["EP\/J020990\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/K005278"],"award-info":[{"award-number":["EP\/K005278"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"EU-FP7 project","doi-asserted-by":"publisher","award":["FP7-ICT-2011-9-601055"],"award-info":[{"award-number":["FP7-ICT-2011-9-601055"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR Biomedical Research Unit (Dementia)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC10269"],"award-info":[{"award-number":["BRC10269"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR Biomedical Research Unit (Dementia)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"EPSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000319","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000319","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000368","name":"Brain Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative (ADNI)","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"DOD ADNI","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Araclon Biotech"},{"DOI":"10.13039\/100007742","name":"BioClinica, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CereSpir, Inc"},{"DOI":"10.13039\/501100003769","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elan Pharmaceuticals, Inc"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EuroImmun"},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005062","name":"Fujirebio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IXICO Ltd."},{"name":"Janssen Alzheimer Immunotherapy Research and Development, LLC"},{"name":"Johnson and Johnson Pharmaceutical Research and Development LLC"},{"name":"Lumosity"},{"DOI":"10.13039\/501100003554","name":"Lundbeck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck and Co, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NeuroRx Research"},{"name":"Neurotrack Technologies"},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Piramal Imaging"},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Transition Therapeutics"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009804","name":"Northern California Institute for Research and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neurobiolaging.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T03:32:07Z","timestamp":1485401527000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["APOE \u03b54 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5753-428X","authenticated-orcid":false,"given":"Carole H.","family":"Sudre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jorge","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-3706","authenticated-orcid":false,"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Ourselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/jcbfm.2015.121","article-title":"Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons","volume":"36","author":"Abraham","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","article-title":"Human apolipoprotein E \u025b4 expression impairs cerebral vascularization and blood\u2013brain barrier function in mice","volume":"35","author":"Alata","year":"2014","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid \u03b2-amyloid(1-42) in Alzheimer disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib5","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.neurobiolaging.2013.04.023","article-title":"Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease","volume":"34","author":"Benedictus","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jalz.2014.07.155","article-title":"APOE \u03b54 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?","volume":"10","author":"Brickman","year":"2014","journal-title":"Alzheimer's Demen."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.euroneuro.2014.01.023","article-title":"Brain imaging in type 2 diabetes","volume":"24","author":"Brundel","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib8","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1109\/TMI.2015.2418298","article-title":"Geodesic information flows: spatially-variant graphs and their application to segmentation and fusion","volume":"34","author":"Cardoso","year":"2015","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib9","series-title":"Four Tissue Segmentation in ADNI\u00a0II","author":"De Carli","year":"2013"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.STR.0000125859.71051.83","article-title":"Interaction between hypertension, apoE, and cerebral white matter lesions","volume":"35","author":"De Leeuw","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","article-title":"Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease","volume":"67","author":"Donahue","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/bpa.12221","article-title":"Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA","volume":"25","author":"Esiri","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuroimage.2011.01.077","article-title":"Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials","volume":"57","author":"Fox","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/jcbfm.2015.85","article-title":"APOE \u025b2 is associated with white matter hyperintensity volume in CADASIL","volume":"36","author":"Gesierich","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib15","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1161\/STROKEAHA.109.555839","article-title":"Apolipoprotein E genotype is related to progression of white matter lesion load","volume":"40","author":"Godin","year":"2009","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1016\/j.neurobiolaging.2017.01.014_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000049149","article-title":"Cerebral amyloid angiopathy and vessel dysfunction","volume":"13","author":"Greenberg","year":"2002","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fnagi.2015.00115","article-title":"Impaired A\u03b2 clearance: a potential link between atherosclerosis and Alzheimer's disease","volume":"7","author":"Gupta","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000063606","article-title":"Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy\u2013a histopathological assessment","volume":"14","author":"Haglund","year":"2002","journal-title":"Demen. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/STROKEAHA.107.497438","article-title":"Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging","volume":"39","author":"Holland","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib20","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.neurobiolaging.2013.05.009","article-title":"Effects of APOE \u03b54 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment","volume":"34","author":"Kim","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.0b013e31826c1b9d","article-title":"Vascular burden and Alzheimer disease pathologic progression","volume":"79","author":"Lo","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib22","doi-asserted-by":"crossref","first-page":"024003","DOI":"10.1117\/1.JMI.1.2.024003","article-title":"Global image registration using a symmetric block-matching approach","volume":"1","author":"Modat","year":"2014","journal-title":"J.\u00a0Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cmpb.2009.09.002","article-title":"Fast free-form deformation using graphics processing units","volume":"98","author":"Modat","year":"2010","journal-title":"Computer Methods Programs Biomed."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/09540261.2013.838151","article-title":"Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia","volume":"25","author":"Mortamais","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib25","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","article-title":"Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in\u00a0vitro blood-brain barrier model","volume":"286","author":"Nishitsuji","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.0000000000001283","article-title":"Smoking and white matter hyperintensity progression the ARIC-MRI Study","volume":"84","author":"Power","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamaneurol.2013.1321","article-title":"White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?","volume":"70","author":"Provenzano","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroimage.2011.02.076","article-title":"Avoiding asymmetry-induced bias in longitudinal image processing","volume":"57","author":"Reuter","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib29","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/01.wnl.0000251302.55202.73","article-title":"Progression of white matter hyperintensities in elderly individuals over 3 years","volume":"68","author":"Sachdev","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-510X(02)00288-5","article-title":"Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease","volume":"203\u2013204","author":"Salloway","year":"2002","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib32","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(03)13616-1","article-title":"Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study","volume":"361","author":"Schmidt","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1212\/01.wnl.0000234030.77831.5a","article-title":"Associations between white matter lesions, cerebrovascular risk factors, and low CSF A\u03b2-42","volume":"67","author":"Stenset","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1109\/TMI.2015.2419072","article-title":"Bayesian model selection for pathological neuroimaging data applied to white matter lesion segmentation","volume":"34","author":"Sudre","year":"2015","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib35","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/STROKEAHA.107.513176","article-title":"Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study","volume":"39","author":"van Dijk","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib36","series-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1212\/WNL.0000000000001379","article-title":"Effects of vascular risk factors and APOE e 4 on white matter integrity and cognitive decline","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib39","first-page":"1140","article-title":"What are white matter hyperintensities made of? Relevance to vascular cognitive impairment","volume":"4","author":"Wardlaw","year":"2015","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fneur.2013.00205","article-title":"Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations","volume":"4","author":"Yates","year":"2014","journal-title":"Front. Neurol."},{"issue":"3 Suppl","key":"10.1016\/j.neurobiolaging.2017.01.014_bib41","first-page":"S16","article-title":"Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit","volume":"40","author":"Zipfel","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.01.014_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017300222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017300222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:24:53Z","timestamp":1759317893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458017300222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":42,"alternative-id":["S0197458017300222"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.014","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE \u03b54 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}